KALA BIO, Inc. KALA
0.18 USD +0.01 (+2.95%)
At closeNov 4, 2026, 4:00 PM EST
0.18 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
0.1721 Day range 0.1852
0.115 52-week range 95.50
- YTD
- -99.36%
- 1 year
- -99.53%
Analyst view
Price target (mean) 15.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.47 | -2.47 – -2.47 | -1.58 | -56.2% | 0 | 0.0% | 1 |
| Next quarter | -2.57 | -2.57 – -2.57 | -3.19 | +19.3% | 0 | 0.0% | 1 |
| Current year | -11.07 | -11.07 – -11.07 | -13.43 | +17.6% | 0 | 0.0% | 1 |
| Next year | -6.02 | -6.02 – -6.02 | -11.07 | +45.6% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 19, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 17, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 1, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Nov 17, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 12, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 27, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 6, 2023 | HC Wainwright & Co. | Maintained | — | Buy |